Table 1 Clinical and pathological features of patients with bladder cancer and controls
From: Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis
Variables | No. of patients (%) | No. of controls (%) |
|---|---|---|
No. | 305 | 34 |
Mean age ± SD | 65.0 ± 12.6 | 53.8 ± 14.9 |
Gender | ||
Male | 253 (83.0) | 19 (55.9) |
Female | 52 (17.0) | 15 (44.1) |
Grade | ||
G1 | 56 (18.4) | |
G2 | 132 (43.3) | |
G3 | 117 (38.4) | |
T stage | ||
Ta | 48 (15.7) | |
T1 | 136 (44.6) | |
T2 | 55 (18.0) | |
T3 | 38 (12.5) | |
T4 | 28 (9.2) | |
N stage | ||
N0 | 274 (89.8) | |
N(1–3) | 31 (10.2) | |
M stage | ||
M0 | 287 (94.1) | |
M1 | 18 (5.9) | |
Median follow-up period (months) |